549 related articles for article (PubMed ID: 1691287)
1. Clinical, virologic, and immunologic effects of combination therapy with ribavirin and isoprinosine in HIV-infected homosexual men.
Schulof RS; Parenti DM; Simon GL; Paxton H; Meyer WA; Schlesselman SB; Courtless J; LeLacheur S; Sztein MB
J Acquir Immune Defic Syndr (1988); 1990; 3(5):485-92. PubMed ID: 1691287
[TBL] [Abstract][Full Text] [Related]
2. [Virus diseases treated with isoprinosine and ribavirin (author's transl)].
Propper P; Kopecký J
Cas Lek Cesk; 1982 Jan; 121(1):22-4. PubMed ID: 6173129
[No Abstract] [Full Text] [Related]
3. The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection. The Scandinavian Isoprinosine Study Group.
Pedersen C; Sandström E; Petersen CS; Norkrans G; Gerstoft J; Karlsson A; Christensen KC; Håkansson C; Pehrson PO; Nielsen JO
N Engl J Med; 1990 Jun; 322(25):1757-63. PubMed ID: 1693173
[TBL] [Abstract][Full Text] [Related]
4. Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS.
Bekesi JG; Tsang PH; Wallace JI; Roboz JP
J Clin Lab Immunol; 1987 Dec; 24(4):155-61. PubMed ID: 2452254
[TBL] [Abstract][Full Text] [Related]
5. A phase 1 study of ribavirin in human immunodeficiency virus-infected patients.
Roberts RB; Jurica K; Meyer WA; Paxton H; Makuch RW
J Infect Dis; 1990 Sep; 162(3):638-42. PubMed ID: 2117625
[TBL] [Abstract][Full Text] [Related]
6. T-lymphocyte populations in hepatitis C and HIV co-infected patients treated with interferon-alfa-2a and ribavirin.
Neau D; Galpérine T; Legrand E; Pitard V; Neau-Cransac M; Moreau JF; Ragnaud JM; Dupon M; Fleury H; Lafon ME
HIV Med; 2003 Apr; 4(2):120-6. PubMed ID: 12702132
[TBL] [Abstract][Full Text] [Related]
7. Effects of isoprinosine treatment of HIV-positive patients on blood mononuclear cell subsets, NK- and T-cell function, tumour necrosis factor, and interleukins 1, 2, and 6.
Pedersen BK; Tvede N; Diamant M; Gerstoft J; Bagge Hansen M; Haahr PM; Hørding M; Kappel M; Klokker M; Søeberg B
Scand J Immunol; 1990 Dec; 32(6):641-9. PubMed ID: 1702899
[TBL] [Abstract][Full Text] [Related]
8. Effect of isoprinosine on HIV antigenaemia.
Teglbjaerg LL; Kroon S; Sandström E; Moestrup T; Hansson BG; Vestergaard BF
AIDS; 1992 Feb; 6(2):199-201. PubMed ID: 1373064
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex. A randomised, multicentric study.
De Simone C; Albertini F; Almaviva M; Angarano G; Chiodo F; Costigliola P; Delia S; Ferlini A; Gritti F; Mazzarello G
Med Oncol Tumor Pharmacother; 1989; 6(1):63-7. PubMed ID: 2471025
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human T lymphocyte functions by isoprinosine.
Rey A; Cupissol D; Thierry C; Esteve C; Serrou B
Int J Immunopharmacol; 1983; 5(1):99-103. PubMed ID: 6188707
[TBL] [Abstract][Full Text] [Related]
11. Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics.
Lifson AR; Buchbinder SP; Sheppard HW; Mawle AC; Wilber JC; Stanley M; Hart CE; Hessol NA; Holmberg SD
J Infect Dis; 1991 May; 163(5):959-65. PubMed ID: 1673465
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of rheumatoid arthritis with isoprinosine. Personal experience].
Bouvier M; Bonvoisin B; Lejeune E; Sidot C; Touraine JL; Touraine F
Rev Rhum Mal Osteoartic; 1983 Oct; 50(10):653-7. PubMed ID: 6196834
[TBL] [Abstract][Full Text] [Related]
13. A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.
Japour AJ; Lertora JJ; Meehan PM; Erice A; Connor JD; Griffith BP; Clax PA; Holden-Wiltse J; Hussey S; Walesky M; Cooney E; Pollard R; Timpone J; McLaren C; Johanneson N; Wood K; Booth D; Bassiakos Y; Crumpacker CS
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Nov; 13(3):235-46. PubMed ID: 8898668
[TBL] [Abstract][Full Text] [Related]
14. A multicenter clinical trial of oral ribavirin in HIV-infected people with lymphadenopathy: virologic observations. Ribavirin-LAS Collaborative Group.
Roberts RB; Hollinger FB; Parks WP; Rasheed S; Laurence J; Heseltine PN; Makuch RW; Lubina JA; Johnson KM
AIDS; 1990 Jan; 4(1):67-72. PubMed ID: 1690551
[TBL] [Abstract][Full Text] [Related]
15. Neopterin and beta 2-microglobulin as serum markers in a placebo-controlled anti-HIV therapy trial.
Carstens J; Teglbjaerg LS; Black FT
Eur J Clin Chem Clin Biochem; 1995 Sep; 33(9):559-62. PubMed ID: 8611664
[TBL] [Abstract][Full Text] [Related]
16. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.
Beran J; Špajdel M; Slíva J
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835052
[TBL] [Abstract][Full Text] [Related]
17. Isoprinosine and Imuthiol, two potentially active compounds in patients with AIDS-related complex symptoms.
Pompidou A; Delsaux MC; Telvi L; Mace B; Coutance F; Falkenrodt A; Lang JM
Cancer Res; 1985 Sep; 45(9 Suppl):4671s-4673s. PubMed ID: 2410111
[TBL] [Abstract][Full Text] [Related]
18. Ribavirin and inosiplex: a review of their present status in viral diseases.
Chang TW; Heel RC
Drugs; 1981 Aug; 22(2):111-28. PubMed ID: 6167418
[TBL] [Abstract][Full Text] [Related]
19. Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases.
Sliva J; Pantzartzi CN; Votava M
Adv Ther; 2019 Aug; 36(8):1878-1905. PubMed ID: 31168764
[TBL] [Abstract][Full Text] [Related]
20. Isoprinosine enhances PHA responses and has potential effect on natural killer cell (NK) activity of uremic patients in vitro.
Silvennoinen-Kassinen S; Karttunen R; Tiilikainen A; Huttunen K
Nephron; 1987; 46(3):243-6. PubMed ID: 2442634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
